title: Inhibition and active sites of UDP-glucuronosyltransferases 2B7 and 1A1.
abstract: Two human UDP-glucuronosyltransferases (UGTs), UGT2B7 and UGT1A1, catalyze the glucuronidation of many endo- and xenobiotics. Although UGT1A1 uniquely catalyzes the glucuronidation of the endobiotic, bilirubin, and UGT2B7 uniquely catalyzes the glucuronidation of morphine to both the 3-0 glucuronide and the 6-0 glucuronide, both catalyze the glucuronidation of the mixed opioid agonist/antagonist buprenorphine with high efficiency. Etonitazenyl, a mu opioid receptor antagonist, was found to inhibit competitively opioid, steroid, and other substrate glucuronidation reactions catalyzed by UGT2B7. Data showing several benzodiazepines and alternative substrates interacting competitively support previous work, which indicates a single binding domain within UGT2B7. Etonitazenyl also competitively inhibited the glucuronidation of buprenorphine catalyzed by UGT1A1. However, neither etonitazenyl nor buprenorphine inhibited bilirubin glucuronidation except at very high concentrations. Therefore, it is unlikely that buprenorphine therapy for opioid or other drug addiction would influence bilirubin glucuronidation and lead to hyperbilirubenmia. Anthraflavic acid and catechol estrogen glucuronidation, catalyzed by UGT1A1, was also not inhibited by etonitazenyl or buprenorphine. Reactions catalyzed by UGT1A6 were not affected by etonitazenyl. These studies indicate that UGT2B7 has one binding site and that UGT1A1 has two or more binding sites for xenobiotics and endobiotics.
authors.affiliation: Department of Pharmacology, University of Iowa, Iowa City 52242, Iowa, USA. gladys-rios@uiowa.edu
authors.forename: Gladys R
authors.initials: GR
authors.lastname: Rios
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Tephly
mesh_terms: D000738:Androsterone / Q000378:metabolism / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects / Q000502:physiology; D002047:Buprenorphine / Q000378:metabolism / Q000494:pharmacology; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D014453:Glucuronosyltransferase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D009020:Morphine / Q000378:metabolism / Q000494:pharmacology; D000099148:UGT1A1 Enzyme
chemical_list: D000738:Androsterone; D002047:Buprenorphine; D014453:Glucuronosyltransferase; D009020:Morphine; D000099148:UGT1A1 Enzyme; C491474:UGT2B7 protein, human